Skip to content
Search

Latest Stories

UK reports first death with Omicron coronavirus variant

At least one person has died in the United Kingdom after contracting the Omicron coronavirus variant, prime minister Boris Johnson said on Monday (December 13) -- the first publicly confirmed death globally from the swiftly spreading virus strain.

Since the first Omicron cases were detected on November 27 in Britain, Johnson has imposed tougher restrictions and on Sunday cautioned that the variant could overcome the immune defences of those inoculated with two shots of vaccines.


Britain gave no details on the death other than the person had been diagnosed in hospital. It was not clear if the patient had been vaccinated or had underlying health issues.

Deaths from Omicron may have occurred in other countries but none has been publicly confirmed yet outside Britain.

"Sadly at least one patient has now been confirmed to have died with Omicron," Johnson told reporters at a vaccination centre in London.

"So I think the idea that this is somehow a milder version of the virus -- I think that's something we need to set (to) one side -- and just recognise the sheer pace at which it accelerates through the population."

Health secretary Sajid Javid said the variant now accounted for 44 per cent of infections in London and would be the dominant strain in the capital within 48 hours.

New Omicron infections are estimated at 200,000 per day, Javid said.

Before the death was announced, Britain said 10 people had been hospitalised with Omicron in various parts of England. Their ages ranged from 18 to 85 years and most had received two vaccination doses.

The UK Health Security Agency said Omicron -- first detected in South Africa, Botswana and Hong Kong in late November -- can overcome the immunity of those who have had two shots of vaccines such as AstraZeneca or Pfizer-BioNTech .

South Africa's health ministry said it was unable to say with certainty if any of its COVID-19 deaths were caused by Omicron as deaths were not broken down by variant.

The World Health Organization said on Sunday that while preliminary findings from South Africa suggest Omicron may be less severe than the Delta variant -- currently dominant worldwide, and all cases reported in the Europe region have been mild or asymptomatic, it remains unclear to what extent Omicron may be inherently less virulent.

New lockdowns?

Johnson, now grappling with a rebellion in his party over measures to curb Omicron and an outcry over staff parties at his Downing Street office during last year's lockdowns, said people should rush to get booster vaccines to protect "our freedoms and our way of life".

After Covid-19 was first detected in China in late 2019, he faced criticism for initially resisting lockdown.

He has also been criticised for overseeing mistakes in transferring patients into care homes, and for building a costly test-and-trace system that failed to stop a deadly second wave.

Johnson has repeatedly said that while mistakes were made, the government was making decisions swiftly in the biggest public health crisis for generations and that it was quick to roll out vaccines.

More than 146,000 people have died from Covid-19 in the United Kingdom.

Asked if he could rule out tougher restrictions in England before Christmas, Johnson avoided giving a direct answer. His health minister, Javid, said he knew of no plans for additional measures. "There are no plans that I am aware of for any further restrictions," Javid said.

Vaccine queues

At St. Thomas' Hospital Vaccination Centre in central London, a queue of hundreds of people snaked back onto Westminster Bridge. Reuters journalists also documented queues across London and in Manchester, northern England.

"The Covid vaccine booking service is currently facing extremely high demand so is operating a queuing system," the National Health Service said on Twitter. It suggested trying again later.

Home testing kits were also unavailable to order.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less